Home / Market Reports / Medical Devices & Consumables / Global Drug Eluting Coronary Stent System Market Growth 2024-2030

Global Drug Eluting Coronary Stent System Market Growth 2024-2030

Global Drug Eluting Coronary Stent System Market Growth 2024-2030

Product Code:1240289

Published Date: Nov 22,2024

Pages: 119

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Drug Eluting Coronary Stent System market size is predicted to grow from US$ 5834 million in 2024 to US$ 7557 million in 2030; it is expected to grow at a CAGR of 4.4% from 2024 to 2030.

The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.

United States market for Drug Eluting Coronary Stent System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Drug Eluting Coronary Stent System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Drug Eluting Coronary Stent System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Drug Eluting Coronary Stent System players cover Boston Scientific, Medtronic, Abbott, B.Braun, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Drug Eluting Coronary Stent System Industry Forecast” looks at past sales and reviews total world Drug Eluting Coronary Stent System sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug Eluting Coronary Stent System sales for 2024 through 2030. With Drug Eluting Coronary Stent System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Coronary Stent System industry.

This Insight Report provides a comprehensive analysis of the global Drug Eluting Coronary Stent System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Coronary Stent System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Eluting Coronary Stent System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Coronary Stent System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Coronary Stent System.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Coronary Stent System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Rapamycin Eluting Stent
    Everolimus Eluting Stent
    Others

Segmentation by Application:
    Hospitals
    Clinic
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Boston Scientific
    Medtronic
    Abbott
    B.Braun
    BD
    Biotronik AG
    Stentys SA
    Sino Medical
    Beijing ESSEN Technology
    Beijing Advanced Medical Technologies
    LifeTech Scientific Corporation
    MicroPort Scientific Corporation
    Yilson Medical Technology
    Lepu Medical Technology
    Shandong Hua'an Biotechnology

Key Questions Addressed in this Report
What is the 10-year outlook for the global Drug Eluting Coronary Stent System market?
What factors are driving Drug Eluting Coronary Stent System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Coronary Stent System market opportunities vary by end market size?
How does Drug Eluting Coronary Stent System break out by Type, by Application?